Table 5.

Differences in routes of administration and dosing of infliximab (IFX) and adalimumab (ADL) in CD and UC [78,92].

Biologics	Route	Induction Dose (CD and UC)	Maintenance Dose (CD and UC)
IFX	i.v.	5 mg/kg; Weeks: 0, 2, 6.	5–10 * mg/kg; Every 8 weeks.
ADL	s.c.	160 mg day 1, and 2; + 80 mg on day 15. or 80 mg Days: 1, 2, 15.	40 mg Every 2 weeks **. * Higher dose is recommended in the case of unsustained response to IFX ** Initial start on day 29

i.v.—intravenous route; s.c.—subcutaneous route; CD—Crohn’s disease; UC—ulcerative colitis.